Annual Drug Patent Expirations for RESTASIS+MULTIDOSE Restasis Multidose is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are ten patents…
The post New patent for Allergan drug RESTASIS MULTIDOSE appe…
Annual Drug Patent Expirations for RESTASIS Restasis is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are ten patents protecting…
The post New patent for Allergan drug RESTASIS appeared first on DrugP…
Fesoterodine fumarate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Zydus Pharms, and Pfizer and, and is included…
The post New tentative approval for Amneal Pharms drug fesoterodin…
New tentative approval for Amneal Pharms drug fesoterodine fumarate Read Post »
Annual Drug Patent Expirations for SPIRIVA+RESPIMAT Spiriva Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Boehringer Ingelheim drug…
New patent expiration for Boehringer Ingelheim drug SPIRIVA RESPIMAT Read Post »
This chart shows the drugs with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Serbia? …
Which pharmaceutical drugs have the most drug patents in Serbia? Read Post »
Annual Drug Patent Expirations for AURYXIA Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Keryx Biopharms drug AURYXIA appeared …
New patent expiration for Keryx Biopharms drug AURYXIA Read Post »
Fesoterodine fumarate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Zydus Pharms, and Pfizer and, and is included…
The post New tentative approval for Amneal Pharms drug fesoterodin…
New tentative approval for Amneal Pharms drug fesoterodine fumarate Read Post »
Annual Drug Patent Expirations for LIVMARLI Livmarli is a drug marketed by Mirum and is included in one NDA. The generic ingredient in LIVMARLI is maralixibat chloride. Additional details are…
The post New patent for MIRUM drug LIVMARLI appeared first …
Annual Drug Patent Expirations for DRIZALMA+SPRINKLE Drizalma Sprinkle is a drug marketed by Sun Pharma Global and is included in one NDA. It is available from one supplier. There are…
The post New patent for Sun Pharma drug DRIZALMA SPRINKLE appeared …
New patent for Sun Pharma drug DRIZALMA SPRINKLE Read Post »
This chart shows the drugs with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Poland? …
Which pharmaceutical drugs have the most drug patents in Poland? Read Post »
Get new actionable insights and updates from BiotechBlog
